We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Pharmacotherapy of canine atopic dermatitis -- current state and new trends.
- Authors
BÄUMER, Wolfgang
- Abstract
This review offers a concise overview of current treatment options for canine atopic dermatitis and provide an outline of two promising new treatment options (phosphodiesterase 4 and histamine H4 receptor inhibitors). Glucocorticoids have been one of the first successful treatment options and are still part of the treatment regime. Ciclosporin was introduced more than 15 years ago and is also a main pharmacological treatment option. In 2013, the Janus kinase inhibitor oclacitinib was introduced as a first in class, which is then followed by the anti-canine IL-31 antibody lokivetmab in 2016. Thus, exciting new treatment options have found their way into clinical practice. Apart from these substance classes, antihistamines, essential fatty acids and lipid substitution will be discussed as add-on treatments.
- Subjects
ATOPIC dermatitis; ESSENTIAL fatty acids; HISTAMINE receptors; DRUG therapy
- Publication
Veterinary Journal of Ankara University / Ankara Universitesi Veteriner Fakultesi Dergisi, 2020, Vol 67, Issue 2, p107
- ISSN
1300-0861
- Publication type
Article
- DOI
10.33988/auvfd.644485